Real-time enrollment status for this small cell lung cancer metastatic or locally advanced clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:46 PM UTC
| NCT Number | NCT07080242 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer Metastatic or Locally Advanced |
| Phase | PHASE1 |
| Target Enrollment | 120 participants |
| Active Locations | 24 sites in the US |
| Sponsor | SystImmune Inc. |
| Last Updated on CT.gov | September 16, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT07080242 is currently recruiting participants. This phase1 study for small cell lung cancer metastatic or locally advanced is actively seeking new participants at 24 locations across the United States. The study is sponsored by SystImmune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07080242 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07080242 was last updated 3 weeks ago (September 16, 2026). HelloStudys verifies this status automatically.